• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从病理和免疫组化角度看血栓闭塞性脉管炎中闭塞性动脉内膜炎在伯格氏病发病机制中的作用

Endarteritis obliterans in the pathogenesis of Buerger's disease from the pathological and immunohistochemical points of view.

作者信息

Kobayashi Masayoshi, Sugimoto Masayuki, Komori Kimihiro

机构信息

Division of Vascular Surgery, Department of Surgery, Graduate School of Medicine, Nagoya University.

出版信息

Circ J. 2014;78(12):2819-26. doi: 10.1253/circj.cj-14-0656. Epub 2014 Oct 8.

DOI:10.1253/circj.cj-14-0656
PMID:25298073
Abstract

Buerger's disease (thromboangiitis obliterans) is considered to be a nonatherosclerotic, inflammatory, and vaso-occlusive disease, although the details of the mechanisms of pathogenesis remain unknown. The occurrence of the disease is strongly related to tobacco abuse and its progression is closely linked to continued smoking. The purpose of this review article is to demonstrate the pathological characteristics of arteries affected with Buerger's disease from a possible immunoreactive point of view. In addition, we present the mechanisms for preserving the architecture of the arterial wall in affected vasculatures. Thereafter, we discuss the possibility that the pathogenesis of Buerger's disease is a type of endarteritis obliterans, deeply connected to the Notch pathway, distinct from arteriosclerosis obliterans and other vasculitides.

摘要

血栓闭塞性脉管炎被认为是一种非动脉粥样硬化性、炎症性和血管闭塞性疾病,尽管其发病机制的细节仍不清楚。该疾病的发生与烟草滥用密切相关,其进展与持续吸烟紧密相连。这篇综述文章的目的是从可能的免疫反应角度阐述受血栓闭塞性脉管炎影响的动脉的病理特征。此外,我们还介绍了在受影响的脉管系统中维持动脉壁结构的机制。此后,我们讨论了血栓闭塞性脉管炎的发病机制是一种与Notch通路深度相关的闭塞性动脉内膜炎的可能性,它不同于动脉硬化闭塞症和其他血管炎。

相似文献

1
Endarteritis obliterans in the pathogenesis of Buerger's disease from the pathological and immunohistochemical points of view.从病理和免疫组化角度看血栓闭塞性脉管炎中闭塞性动脉内膜炎在伯格氏病发病机制中的作用
Circ J. 2014;78(12):2819-26. doi: 10.1253/circj.cj-14-0656. Epub 2014 Oct 8.
2
Immunohistochemical properties in the patients with Buerger's disease--possible role of plasminogen activator inhibitor-1 for preservation of vessel wall architecture.Buerger 病患者的免疫组织化学特性——纤溶酶原激活物抑制剂-1 对血管壁结构保护的可能作用。
Cardiovasc Pathol. 2011 Sep-Oct;20(5):266-71. doi: 10.1016/j.carpath.2010.06.012. Epub 2010 Aug 12.
3
Immunohistochemical analysis of arterial wall cellular infiltration in Buerger's disease (endarteritis obliterans).血栓闭塞性脉管炎(闭塞性动脉内膜炎)动脉壁细胞浸润的免疫组织化学分析。
J Vasc Surg. 1999 Mar;29(3):451-8. doi: 10.1016/s0741-5214(99)70273-9.
4
Pathogenesis of thromboangiitis obliterans: Gene polymorphism and immunoregulation of human vascular endothelial cells.血栓闭塞性脉管炎的发病机制:人类血管内皮细胞的基因多态性和免疫调节。
Atherosclerosis. 2017 Oct;265:258-265. doi: 10.1016/j.atherosclerosis.2017.08.009. Epub 2017 Aug 18.
5
Current pathological and clinical aspects of Buerger's disease in Japan.日本血栓闭塞性脉管炎的当前病理及临床状况
Ann Vasc Surg. 2006 Jan;20(1):148-56. doi: 10.1007/s10016-005-9436-2.
6
Pathology and pathogenesis of Buerger's disease.
Int J Cardiol. 1998 Oct 1;66 Suppl 1:S237-42. doi: 10.1016/s0167-5273(98)00174-0.
7
Thromboangiitis obliterans. An update on Buerger's disease.血栓闭塞性脉管炎。关于伯格氏病的最新进展。
West J Med. 1998 Apr;168(4):255-60.
8
Thromboangiitis obliterans (Buerger's disease) in a saphenous vein arterial graft.大隐静脉动脉移植物中的血栓闭塞性脉管炎(伯格氏病)
Hum Pathol. 1987 Apr;18(4):402-4. doi: 10.1016/s0046-8177(87)80174-0.
9
Visceral intestinal Buerger's disease.内脏型肠白塞病
Int J Cardiol. 1998 Oct 1;66 Suppl 1:S249-56. doi: 10.1016/s0167-5273(98)00176-4.
10
Thromboangiitis obliterans (Buerger's disease) in an elderly man after cessation of cigarette smoking--a case report.一名老年男性戒烟后发生血栓闭塞性脉管炎(伯格氏病)——病例报告
Angiology. 1987 Nov;38(11):864-7. doi: 10.1177/000331978703801110.

引用本文的文献

1
Comparative Analysis of Transcriptome Profiles in Patients with Thromboangiitis Obliterans.血栓闭塞性脉管炎患者转录组图谱的比较分析
Genes (Basel). 2023 Dec 21;15(1):19. doi: 10.3390/genes15010019.
2
Baiying qingmai formulation ameliorates thromboangiitis obliterans by inhibiting HMGB1/RAGE/NF-κB signaling pathways.白英清脉方通过抑制HMGB1/RAGE/NF-κB信号通路改善血栓闭塞性脉管炎。
Front Pharmacol. 2022 Oct 11;13:1018438. doi: 10.3389/fphar.2022.1018438. eCollection 2022.
3
An Unusual Case of Buerger's Disease in a Pregnant Female.
一名怀孕女性患血栓闭塞性脉管炎的罕见病例。
Cureus. 2022 Aug 25;14(8):e28382. doi: 10.7759/cureus.28382. eCollection 2022 Aug.
4
Long-Term Outcomes of Peripheral Blood Mononuclear Cells in the Treatment of Angiitis-Induced No-Option Critical Limb-Threatening Ischemia.外周血单个核细胞治疗血管炎所致无选择余地的严重肢体威胁性缺血的长期结局
Front Cardiovasc Med. 2021 Dec 6;8:769472. doi: 10.3389/fcvm.2021.769472. eCollection 2021.
5
Three-year outcomes of peripheral blood mononuclear cells vs purified CD34 cells in the treatment of angiitis-induced no-option critical limb ischemia and a cost-effectiveness assessment: A randomized single-blinded noninferiority trial.外周血单个核细胞与纯化 CD34 细胞治疗血管炎导致的无选择重症肢体缺血的 3 年结果和成本效益评估:一项随机单盲非劣效性试验。
Stem Cells Transl Med. 2021 May;10(5):647-659. doi: 10.1002/sctm.20-0033. Epub 2021 Jan 5.
6
The IL-33/sST2 Axis in Thromboangiitis Obliterans.血栓闭塞性脉管炎中的白细胞介素-33/可溶性ST2轴
J Inflamm Res. 2020 Jul 16;13:317-323. doi: 10.2147/JIR.S253980. eCollection 2020.
7
The Association of HLA-A, B and DRB1 with Buerger's Disease.人类白细胞抗原A、B和DRB1与血栓闭塞性脉管炎的关联。
Rep Biochem Mol Biol. 2019 Jul;8(2):153-160.
8
Management of Buerger's Disease in Endovascular Era.血管腔内治疗时代的血栓闭塞性脉管炎管理
Int J Angiol. 2019 Sep;28(3):173-181. doi: 10.1055/s-0039-1685200. Epub 2019 Apr 19.
9
Molecular mechanisms regulating immune responses in thromboangiitis obliterans: A comprehensive review.血栓闭塞性脉管炎中调节免疫反应的分子机制:综述
Iran J Basic Med Sci. 2019 Mar;22(3):215-224. doi: 10.22038/ijbms.2019.31119.7513.
10
Vaso-nervorumitis: responsible for pain in Buerger's disease?血管神经鞘炎:是血栓闭塞性脉管炎疼痛的病因吗?
Int Med Case Rep J. 2019 Apr 29;12:119-123. doi: 10.2147/IMCRJ.S197862. eCollection 2019.